Targovax Hosts Conference Call 12 June 2018

OSLO, Norway, 12 June 2018 /PRNewswire/ — Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing and commercializing immune activating oncology therapies to target, primarily, treatment resistant solid tumors, today hosts a conference call…

PR NEWSWIRE

About M Fund

SITE ADMIN